InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Monday, 04/08/2019 12:00:41 PM

Monday, April 08, 2019 12:00:41 PM

Post# of 202
News: $VLRX Valeritas' V-Go® Wearable Insulin Delivery Device Demonstrates 24% Reduction in Total Daily Insulin Dosage and Lower A1C Compared to Standard Insulin Treatment

BRIDGEWATER, N.J., April 08, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go ® Wearable Insulin Delivery device , today announced the V-GoAL randomized controlled trial of 415 patients across 52 sites. V-Go users ...

Got this from https://marketwirenews.com/news-releases/valeritas-v-go-xae-wearable-insulin-delivery-device-demonstrates-24-reduction-in-total-daily-insulin-dosage-and-lower-a1c-compared-to-standard-insulin-treatment-7961832.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.